| # | Drug | Count |
|---|---|---|
| 0 | METFORMIN | 19 |
| 1 | METFORMIN ER 500 MG | 19 |
| 2 | METFORMIN ER 750 MG | 19 |
| 3 | INSULIN GLARGINE | 18 |
| 4 | ASPIRIN | 12 |
| 5 | ASPIRIN 325 MG | 12 |
| 6 | ASPIRIN 81 MG | 12 |
| 7 | AMLODIPINE | 11 |
| 8 | SITAGLIPTIN | 11 |
| 9 | INSULIN GLARGINE-YFGN | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DIAZOXIDE | 1 | 0.0014 |
| 1 | CHLORPROMAZINE HYDROCHLORIDE | 1 | 0.0010 |
| 2 | MIGLITOL | 1 | 0.0010 |
| 3 | DANTROLENE SODIUM | 1 | 0.0009 |
| 4 | POTASSIUM ACETATE | 1 | 0.0007 |
| 5 | GALANTAMINE HYDROBROMIDE | 1 | 0.0006 |
| 6 | FOSCARBIDOPA/FOSLEVODOPA | 4 | 0.0005 |
| 7 | INSULIN GLARGINE-YFGN | 10 | 0.0004 |
| 8 | TRIAMTERENE | 3 | 0.0004 |
| 9 | INSULIN ASPART INJECTION | 1 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Insulin Analog [EPC] | 27 |
| 1 | Dihydropyridine Calcium Channel Blocker [EPC] | 18 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 16 |
| 3 | Sulfonylurea [EPC] | 15 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 12 |
| 5 | Calcium Channel Blocker [EPC] | 11 |
| 6 | GLP-1 Receptor Agonist [EPC] | 11 |
| 7 | Angiotensin 2 Receptor Blocker [EPC] | 10 |
| 8 | Atypical Antipsychotic [EPC] | 9 |
| 9 | Corticosteroid [EPC] | 9 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Potassium-sparing Diuretic [EPC] | 3 | 0.0002 |
| 1 | alpha-Glucosidase Inhibitor [EPC] | 1 | 0.0002 |
| 2 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 6 | 0.0002 |
| 3 | Phosphodiesterase 3 Inhibitor [EPC] | 1 | 0.0002 |
| 4 | Sulfonylurea [EPC] | 15 | 0.0001 |
| 5 | Vitamin K [EPC] | 1 | 0.0001 |
| 6 | Glinide [EPC] | 1 | 0.0001 |
| 7 | Insulin [EPC] | 4 | 0.0001 |
| 8 | Antimycobacterial [EPC] | 2 | 0.0001 |
| 9 | Melatonin Receptor Agonist [EPC] | 1 | 0.0001 |